Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2020 Apr 8:11:488.
doi: 10.3389/fphar.2020.00488. eCollection 2020.

Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape

Sisi Xie  1 , Shu Li  1 , Jing Tian  1 , Fen Li  1
Affiliations
Published Erratum

Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape

Sisi Xie et al. Front Pharmacol. .

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.00073.].

Keywords: NF-kappa B; iguratimod; pharmacology; randomized controlled trial; rheumatoid arthritis.

PubMed Disclaimer

Erratum for

References

    1. Duan X. W., Zhang X. L., Mao S. Y., Shang J. J., Shi X. D. (2015). Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial. Clin. Rheumatol. 34 (9), 1513–1519. 10.1007/s10067-015-2999-6 - DOI - PubMed
    1. Ebina K., Miyama A., Tsuboi H., Kaneshiro S., Nishikawa M., Owaki H., et al. (2019). The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. Mod. Rheumatol. 29 (4), 581–588. 10.1080/14397595.2018.1486939 - DOI - PubMed
    1. Hara M., Ishiguro N., Katayama K., Kondo M., Sumida T., Mimori T., et al. (2014). Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial. Mod. Rheumatol. 24 (3), 410–418. 10.3109/14397595.2013.843756 - DOI - PubMed
    1. Ishiguro N., Yamamoto K., Katayama K., Kondo M., Sumida T., Mimori T., et al. (2013). Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial. Mod. Rheumatol. 23 (3), 430–439. 10.1007/s10165-012-0724-8 - DOI - PubMed
    1. Suto T., Yonemoto Y., Okamura K., Sakane H., Takeuchi K., Tamura Y., et al. (2019). The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis. Mod. Rheumatol. 29 (5), 775–781. 10.1080/14397595.2018.1510879 - DOI - PubMed

Publication types

LinkOut - more resources